The present invention relates to a therapeutic substance delivery device for delivering a therapeutic substance to a desired site in a bodily duct, characterized in that the therapeutic substance delivery device is provided with: a therapeutic substance loading portion; a connector which is connected to the therapeutic substance loading portion; and a supplying/discharging pipe connected to the connector; and in that the therapeutic substance loading portion includes a main body portion in which a recessed portion is formed, a resilient film, and a connecting pipe; the connector is provided with a joint main body, a flange portion fixed to the other end portion side of the joint main body, and a fixing nut through which the joint main body passes; the joint main body is provided with a tube fastening portion; and at least part of the inner wall of the fixing nut is provided with a thread.

The present application provides a connecting and releasing structure for a balloon system, a balloon system comprising the connecting and releasing structure, and a method for fabricating the same. The connecting and releasing structure is used for connection and release of a catheter and a balloon. The connecting and releasing structure comprises a self-sealing valve positioned on the balloon. The self-sealing valve comprises a catheter connecting port. The catheter passes through the catheter connecting port and is sealedly connected to the self-sealing valve. The self-sealing valve is completely or partially bonded to the inner wall of the balloon. When the catheter is removed after delivery of a filler, the self-sealing valve is not pulled out of the balloon, and thus leakage of the filler can be prevented. In addition, the perimeter of a small orifice in a side wall of the self-sealing valve or the perimeter of the cross-section of the distal end thereof is not greater than the outer diameter of the catheter, and therefore, no leakage occurs when the balloon is full of filler. In addition, the perimeters of cross-sections of the self-sealing valve may differ and increase gradually or stepwise from distal to proximal, thus facilitating the insertion and removal of the catheter.

An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.

Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

The delivery system may include, for example, an outer catheter having a distal tip and an inner support member, such as an inner catheter, disposed within the outer catheter. The inner support member includes an anchor member adjacent a distal tip of the inner support member and a support portion axially inward of the anchor member. The support portion is configured for supporting an implantable device thereon. A diameter of the anchor member corresponds to a diameter of a portion of a vessel in which the anchor member is to be disposed. The anchor member is configured to be lodged in the portion of the vessel to locate an intended position of the anchor member and to prevent movement of the inner support member relative to the vessel during release of the implantable device.

A content inflation and delivery system including a container including a fluid inlet in fluid communication with a fluid outlet; wherein the fluid outlet is positioned between the fluid inlet and a second end of the container. The system also includes an inflatable content being configured for inflation and delivery from the second end of the container.

The present teachings provide devices and methods of reshaping the right heart and reducing tricuspid valve regurgitation. Specifically, one aspect of the present teachings provides an inflatable device to be deployed in the space between the sternum and the right heart. An injectable medium is injected to the cavity of the device. Once the device is filled, the device is detached from the delivery system, and released inside the body. The inflated device exerts pressure to the right heart, changes the shape of the tricuspid annulus, and allows a better coaptation of the tricuspid leaflets.

Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.

An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.